249 related articles for article (PubMed ID: 7481548)
21. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD
Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359
[TBL] [Abstract][Full Text] [Related]
22. Embolisation therapy in the midgut carcinoid syndrome: just tumour ischaemia?
Wängberg B; Geterud K; Nilsson O; Jansson S; Dahlström A; Tylén U; Ahlman H
Acta Oncol; 1993; 32(2):251-6. PubMed ID: 7686767
[TBL] [Abstract][Full Text] [Related]
23. Repeated hepatic ischemia in combination with chemotherapy for liver carcinoid metastases.
Van Cutsem E; Penninckx F; Filez L; Kerremans R; Vantrappen G
Acta Gastroenterol Belg; 1993; 56(3-4):292-5. PubMed ID: 8266772
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of metastatic carcinoid tumors with interferon-alpha. Five cases].
Votte A; Iglicki F; Sévenet F; Tabah I; Dupas JL
Presse Med; 1996 Jan; 25(2):63-7. PubMed ID: 8745720
[TBL] [Abstract][Full Text] [Related]
25. Hepatic arterial embolisation in patients with metastatic carcinoid tumours.
Odurny A; Birch SJ
Clin Radiol; 1985 Nov; 36(6):597-602. PubMed ID: 2415290
[TBL] [Abstract][Full Text] [Related]
26. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Clouse ME; Perry L; Stuart K; Stokes KR
Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
[TBL] [Abstract][Full Text] [Related]
27. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.
Dominguez S; Denys A; Madeira I; Hammel P; Vilgrain V; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):151-7. PubMed ID: 10741928
[TBL] [Abstract][Full Text] [Related]
28. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
Norton JA; Kerlan RK
Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
[No Abstract] [Full Text] [Related]
29. Long-term survival of patients with carcinoid tumor and liver metastases.
Stathopoulos GP; Papadopoulos G; Koutantos J
J BUON; 2009; 14(4):609-11. PubMed ID: 20148450
[TBL] [Abstract][Full Text] [Related]
30. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
31. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S
AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
Linkesch M; Kuzmits R; Geyer G
Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
[TBL] [Abstract][Full Text] [Related]
33. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E
Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764
[TBL] [Abstract][Full Text] [Related]
34. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
[TBL] [Abstract][Full Text] [Related]
35. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
Ardill JE; Johnston BT; McCance DR; Eatock M
Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
[TBL] [Abstract][Full Text] [Related]
36. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
[TBL] [Abstract][Full Text] [Related]
37. A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
Veenhof CH; de Wit R; Taal BG; Dirix LY; Wagstaff J; Hensen A; Huldij AC; Bakker PJ
Eur J Cancer; 1992; 28(1):75-8. PubMed ID: 1373635
[TBL] [Abstract][Full Text] [Related]
38. Treatment of liver metastases of carcinoid tumors.
Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
[TBL] [Abstract][Full Text] [Related]
39. Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors.
Lunderquist A; Ericsson M; Nobin A; Sandén G
Radiologe; 1982 Feb; 22(2):65-70. PubMed ID: 7071325
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
